Status:

COMPLETED

Sensitivity of the InSync Sentry OptiVol Feature for the Prediction of Heart Failure

Lead Sponsor:

Medtronic Cardiac Rhythm and Heart Failure

Collaborating Sponsors:

Medtronic

Conditions:

Heart Failure, Congestive

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The SENSE-HF study is a prospective, observational, international multi-center study prospectively evaluating the sensitivity and positive predictive value of the OptiVol Fluid Trends data in predicti...

Detailed Description

The SENSE-HF study prospectively evaluates the OptiVol feature in the prediction of Heart Failure related events associated with signs and symptoms of pulmonary congestion and in the subject HF therap...

Eligibility Criteria

Inclusion

  • Successfully implanted InSync Sentry device (\< 34 days post implant or pocket revision)in the pectoral region;
  • At least one HF-related hospitalization that required administration of IV medication (inotropes, nitrates, diuretics) within the last 12 months
  • The Subject has a market released, transvenous, high voltage Right Ventricular lead
  • The Subject is able to detect a Patient Alert signal

Exclusion

  • \<18 years of age (or under a minimum age required by local law)
  • Moderate to severe Chronic Obstructive Pulmonary Disease (COPD)
  • Post heart transplant or awaiting heart transplantation
  • Primary pulmonary hypertension
  • Renal insufficiency requiring dialysis
  • Amendment to the inclusion criteria (Jul 06):
  • Inclusion of patients with Concerto/Virtuoso devices.
  • At least one HF-related hospitalization that required administration of IV (or uptitration of the oral medication)(inotropes, nitrates, diuretics)within the last 12 months

Key Trial Info

Start Date :

January 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 1 2009

Estimated Enrollment :

501 Patients enrolled

Trial Details

Trial ID

NCT00400985

Start Date

January 1 2005

End Date

August 1 2009

Last Update

July 2 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

UZA

Antwerp, Belgium

2

Royal Brompton

London, United Kingdom